N/A
Completed N=26
CAMS-RAS: for Suicide Prevention
Source: ClinicalTrials.gov NCT03072875 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Jul 2018
Primary outcomePrimary: Usability Satisfaction and Acceptability Questionnaire (USAQ) — 4.5 units on a scale
Summary
This Phase I feasibility study endeavors to create a prototype of a tool to determine its feasibility with suicidal patients in emergency departments (EDs). This is not a clinical trial. The overarching goal of this research is to create a tool that could reduce suicide rates, increase delivery of efficacious suicide interventions, and decrease overall costs associated with suicidal behaviors. SBIR Phase I project aims include: (1) creating an advisory board to guide the development of CAMS-RAS; (2) iteratively design and develop relational agent ("Dr. Dave") modeled after the gestures, expressions, and mannerisms of CAMS treatment developer, David Jobes, PhD; and (3) conduct feasibility tests to determine whether CAMS-RAS is acceptable, easy to use, and liked by target end-users: acutely suicidal patients admitted to hospital EDs, psychiatric inpatient units, and medical floors for treatment of injuries sustained during a suicide attempt; hospital medical personnel, administrators, and other stakeholders including peer advocates; and outpatient suicidal patients, clinicians and administrators.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Usability Satisfaction and Acceptability Questionnaire (USAQ) |
4.5 | — |
| PRIMARY Number of ED Patient Participants Who Completed Semi-Structured Interview |
6 | — |
Eligibility Criteria
Patient Inclusion Criteria:
- English fluency
- 18 years or older
- receiving clinical care in a hospital or outpatient clinic for suicidality
- Suicidal patients currently admitted to EDs, psychiatric inpatient units, and medical floors, or patient with past (last 6 months) suicidality receiving outpatient treatment
Patient Exclusion Criteria:
- Acutely psychotic
- severely agitated (as determined by care team)
Data sourced from ClinicalTrials.gov (NCT03072875). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.